8-27463009-G-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000742.4(CHRNA2):​c.1434C>A​(p.Asp478Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00474 in 1,614,098 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D478N) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0032 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0049 ( 23 hom. )

Consequence

CHRNA2
NM_000742.4 missense

Scores

2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:10

Conservation

PhyloP100: 0.0850

Publications

14 publications found
Variant links:
Genes affected
CHRNA2 (HGNC:1956): (cholinergic receptor nicotinic alpha 2 subunit) Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels formed by a pentameric arrangement of alpha and beta subunits to create distinct muscle and neuronal receptors. Neuronal receptors are found throughout the peripheral and central nervous system where they are involved in fast synaptic transmission. This gene encodes an alpha subunit that is widely expressed in the brain. The proposed structure for nAChR subunits is a conserved N-terminal extracellular domain followed by three conserved transmembrane domains, a variable cytoplasmic loop, a fourth conserved transmembrane domain, and a short C-terminal extracellular region. Mutations in this gene cause autosomal dominant nocturnal frontal lobe epilepsy type 4. Single nucleotide polymorphisms (SNPs) in this gene have been associated with nicotine dependence. [provided by RefSeq, Nov 2009]
CHRNA2 Gene-Disease associations (from GenCC):
  • autosomal dominant nocturnal frontal lobe epilepsy 4
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Illumina, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial sleep-related hypermotor epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • benign familial infantile epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012082964).
BP6
Variant 8-27463009-G-T is Benign according to our data. Variant chr8-27463009-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 136753.
BS2
High AC in GnomAd4 at 485 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000742.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNA2
NM_000742.4
MANE Select
c.1434C>Ap.Asp478Glu
missense
Exon 6 of 7NP_000733.2Q15822-1
CHRNA2
NM_001282455.2
c.1389C>Ap.Asp463Glu
missense
Exon 6 of 7NP_001269384.1Q15822-2
CHRNA2
NM_001347705.2
c.957C>Ap.Asp319Glu
missense
Exon 6 of 7NP_001334634.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNA2
ENST00000407991.3
TSL:5 MANE Select
c.1434C>Ap.Asp478Glu
missense
Exon 6 of 7ENSP00000385026.1Q15822-1
CHRNA2
ENST00000523695.5
TSL:1
n.*836C>A
non_coding_transcript_exon
Exon 6 of 7ENSP00000430612.1E5RJ54
CHRNA2
ENST00000523695.5
TSL:1
n.*836C>A
3_prime_UTR
Exon 6 of 7ENSP00000430612.1E5RJ54

Frequencies

GnomAD3 genomes
AF:
0.00319
AC:
485
AN:
152218
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000941
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00340
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00569
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.00307
AC:
770
AN:
251014
AF XY:
0.00316
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.00217
Gnomad ASJ exome
AF:
0.000695
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000277
Gnomad NFE exome
AF:
0.00556
Gnomad OTH exome
AF:
0.00392
GnomAD4 exome
AF:
0.00491
AC:
7170
AN:
1461762
Hom.:
23
Cov.:
32
AF XY:
0.00476
AC XY:
3459
AN XY:
727196
show subpopulations
African (AFR)
AF:
0.00102
AC:
34
AN:
33480
American (AMR)
AF:
0.00233
AC:
104
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000612
AC:
16
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000336
AC:
29
AN:
86258
European-Finnish (FIN)
AF:
0.000338
AC:
18
AN:
53294
Middle Eastern (MID)
AF:
0.00156
AC:
9
AN:
5768
European-Non Finnish (NFE)
AF:
0.00606
AC:
6738
AN:
1112006
Other (OTH)
AF:
0.00368
AC:
222
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
446
893
1339
1786
2232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
254
508
762
1016
1270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00318
AC:
485
AN:
152336
Hom.:
1
Cov.:
33
AF XY:
0.00307
AC XY:
229
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.000938
AC:
39
AN:
41584
American (AMR)
AF:
0.00340
AC:
52
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.000577
AC:
2
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00569
AC:
387
AN:
68028
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
29
57
86
114
143
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00429
Hom.:
4
Bravo
AF:
0.00310
TwinsUK
AF:
0.00512
AC:
19
ALSPAC
AF:
0.00830
AC:
32
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00547
AC:
47
ExAC
AF:
0.00337
AC:
409
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00578
EpiControl
AF:
0.00468

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
Autosomal dominant nocturnal frontal lobe epilepsy 4 (3)
-
-
3
not provided (3)
-
-
2
not specified (2)
-
-
1
Autosomal dominant nocturnal frontal lobe epilepsy (1)
-
-
1
CHRNA2-related disorder (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
4.2
DANN
Benign
0.78
DEOGEN2
Benign
0.21
T
Eigen
Benign
-0.99
Eigen_PC
Benign
-0.93
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.81
T
M_CAP
Benign
0.018
T
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.51
N
PhyloP100
0.085
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
0.060
N
REVEL
Benign
0.097
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0010
B
Vest4
0.24
MutPred
0.40
Gain of phosphorylation at Y475 (P = 0.0745)
MVP
0.48
MPC
0.18
ClinPred
0.012
T
GERP RS
-6.0
Varity_R
0.11
gMVP
0.47
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56344740; hg19: chr8-27320526; API